Japan’s Device Makers Increasingly Look Elsewhere In Asia For Production
This article was originally published in PharmAsia News
Executive Summary
Japanese makers of medical devices are looking beyond home to other parts of Asia to produce their products. Kawasumi Laboratories, Nihon Kohden, Nipro and Terumo are among the makers of needles, intravenous kits, blood bags and patient-monitoring systems making the move. Nipro alone is investing $44 million in its subsidiary in Thailand to produce intravenous and insulin needles, primarily for sale in China and India. (Click here for more - a subscription may be required
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.